Browsing by Author "Davis, Tanja Andrea"

Now showing 1 - 8 of 8
  • Thumbnail Image
    Item
    Amino acid starvation sensitizes resistant breast cancer to doxorubicin-induced cell death
    (Frontiers Media, 2020) Thomas, Mark; Davis, Tanja Andrea; Nell, Theo; Sishi, Balindiwe J. N. (Jennifer Nonkosazana); Engelbrecht, Anna-Mart
    Many clinical trials are beginning to assess the effectiveness of compounds known to regulate autophagy in patients receiving anti-cancer chemotherapy. However, autophagy inhibition, through exogenous inhibitors, or activation, through starvation, has revealed conflicting roles in cancer management and chemotherapeutic outcome. This study aimed to assess the effect of amino acid starvation on doxorubicin-treated breast cancer cells by assessing the roles of autophagy and apoptosis. An in vitro breast cancer model consisting of the normal breast epithelial MCF12A and the metastatic breast cancer MDAMB231 cells was used. Apoptotic and autophagic parameters were assessed following doxorubicin treatments, alone or in combination with bafilomycin, ATG5 siRNA or amino acid starvation. Inhibition of autophagy, through ATG5 siRNA or bafilomycin treatment, increased caspase activity and intracellular doxorubicin concentrations in MCF12A and MDAMB231 cells during doxorubicin treatment. While amino acid starvation increased autophagic activity and decreased caspase activity and intracellular doxorubicin concentrations in MCF12A cells, no changes in autophagic parameters or caspase activity were observed in MDAMB231 cells. Our in vivo data showed that 24 h protein starvation during high dose doxorubicin treatment resulted in increased survival of tumor-bearing GFP-LC3 mice. Results from this study suggest that short term starvation during doxorubicin chemotherapy may be a realistic avenue for adjuvant therapy, especially with regards to the protection of non-cancerous cells. More research is however, needed to fully understand the regulation of autophagic flux during starvation.
  • Thumbnail Image
    Item
    A characterisation of genes involved in apoptosis resistance
    (Stellenbosch : Stellenbosch University, 2013-03) Davis, Tanja Andrea; February, M. F.; Meyer, M.; Stellenbosch University. Faculty of Science. Dept. of Genetics.
    ENGLISH ABSTRACT: Apoptosis represents a finely orchestrated and highly conserved natural form of cell death. It exhibits unique morphological and biochemical characteristics which culminate in the controlled dismantling of a cell from within followed by its discreet removal by phagocytic cells. Apoptosis is vital for the preservation of cell and tissue homeostasis but also performs several defensive and protective functions. Owing to its importance, apoptosis is highly regulated and a large number of proteins have been shown to mediate and safeguard the process. Furthermore, deregulated or altered levels of apoptosis can have severe pathological consequences; indeed, apoptosis has been shown to play a central role in several diseases, including neurological and autoimmune diseases as well as a variety of cancers. Consequently, the search for apoptotic-based therapies has received much attention and of vital importance to this quest is the characterisation of the specific mediators of apoptosis and their regulation as well as the identification of novel genes or proteins that can have a regulatory effect on apoptosis. It is thus the aim of this study to assist in this characterisation and also to identify novel candidate genes potentially involved in apoptosis. In a previously performed pilot study, three novel candidate genes potentially involved in apoptosis were identified by performing promoter-trap mutagenesis experiments. These genes were lipoic acid synthetase (LIAS), cyclophilin A (CYPA) and ribosomal protein L9 (RPL9). Since the methodology for this pilot study involved the use of functionally haploid cells, it was aimed in this study to verify these results in a diploid mouse cell line. Candidate gene knockdown was achieved by means of RNA interference and apoptosis assays were performed. A potential role for LIAS and CYPA in apoptosis was successfully verified in this study; however this could not be achieved for RPL9 and the gene was thus excluded from further study. In addition, nucleotide sequences isolated during the promoter-trap mutagenesis experiments in the pilot study were also investigated in order to identify additional novel candidate genes involved in apoptosis. By performing nucleotide BLAST searches, two potential candidate genes were identified, namely AHNAK nucleoprotein (AHNAK) and serum amyloid A-like 1 (SAAL1). Further bioinformatic analyses were performed with the four candidate genes in order to ascertain possible associations with apoptosis or cancer. Lastly, to further characterise the four candidate genes, the relative gene expression was investigated by means of quantitative PCR in two cancer and control cell lines. The results revealed significant differential expression for the majority of genes in the cancer cell lines when compared to the control cell lines. In conclusion, this study identified and characterised four novel genes potentially involved in apoptosis. Results obtained during this study can aid in the complete characterisation and functional annotation of these genes. Potential ties to apoptosis and associations with cancer are discussed for all four candidate genes and the possibilities of therapeutic strategies for anticancer treatments involving these candidate genes are noted.
  • Thumbnail Image
    Item
    Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson’s Disease, Alzheimer’s Disease and Type 2 Diabetes Mellitus
    (Nature Research, 2018-11-14) De Waal, Greta M.; Engelbrecht, Lize; Davis, Tanja Andrea; De Villiers, Willem J. S.; Kell, Douglas B.; Pretorius, Etheresia
    Many chronic diseases, including those classified as cardiovascular, neurodegenerative, or autoimmune, are characterized by persistent inflammation. The origin of this inflammation is mostly unclear, but it is typically mediated by inflammatory biomarkers, such as cytokines, and affected by both environmental and genetic factors. Recently circulating bacterial inflammagens such as lipopolysaccharide (LPS) have been implicated. We used a highly selective mouse monoclonal antibody to detect bacterial LPS in whole blood and/or platelet poor plasma of individuals with Parkinson’s Disease, Alzheimer’s type dementia, or Type 2 Diabetes Mellitus. Our results showed that staining is significantly enhanced (P < 0.0001) compared to healthy controls. Aberrant blood clots in these patient groups are characterized by amyloid formation as shown by the amyloid-selective stains thioflavin T and Amytracker™ 480 or 680. Correlative Light-Electron Microscopy (CLEM) illustrated that the LPS antibody staining is located in the same places as where amyloid fibrils may be observed. These data are consistent with the Iron Dysregulation and Dormant Microbes (IDDM) hypothesis in which bacterial inflammagens such as LPS are responsible for anomalous blood clotting as part of the aetiology of these chronic inflammatory diseases.
  • Thumbnail Image
    Item
    Hyperglycaemia in critically ill patients : the immune system’s sweet tooth
    (BioMed Central, 2017) Van Niekerk, Gustav; Davis, Tanja Andrea; Engelbrecht, Anna-Mart
    There is an ongoing debate regarding the efficacy of glycaemic control in critically ill patients. Here we briefly highlight the key function of elevated glucose in critically ill patients, namely, to enable elevation of aerobic glycolysis in rapidly dividing cells. In particular, aerobic glycolysis provides metabolic intermediates necessary for expansion of biomass in immune cells and promotion of tissue repair. Furthermore, we emphasise that insulin may inhibit autophagy, a cell survival process used in the bulk degradation of cellular debris and damaged organelles. These observations provide a rational basis for tolerating elevated glucose levels in certain critically ill patients.
  • Thumbnail Image
    Item
    Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
    (BMC (part of Springer Nature), 2019-08-01) Christowitz, Claudia; Davis, Tanja Andrea; Isaacs, Ashwin; Van Niekerk, Gustav; Hattingh, Suzel; Engelbrecht, Anna-Mart
    Background: Doxorubicin is currently the most effective chemotherapeutic drug used to treat breast cancer. It has, however, been shown that doxorubicin can induce drug resistance resulting in poor patient prognosis and survival. Studies reported that the interaction between signalling pathways can promote drug resistance through the induction of proliferation, cell cycle progression and prevention of apoptosis. The aim of this study was therefore to determine the effects of doxorubicin on apoptosis signalling, autophagy, the mitogen-activated protein kinase (MAPK)- and phosphoinositide 3-kinase (PI3K)/Akt signalling pathway, cell cycle control, and regulators of the epithelial-mesenchymal transition (EMT) process in murine breast cancer tumours. Methods: A tumour-bearing mouse model was established by injecting murine E0771 breast cancer cells, suspended in Hank’s Balances Salt Solution and Corning® Matrigel® Basement Membrane Matrix, into female C57BL/ 6 mice. Fourty-seven mice were randomly divided into three groups, namely tumour control (received Hank’s Balances Salt Solution), low dose doxorubicin (received total of 6 mg/ml doxorubicin) and high dose doxorubicin (received total of 15 mg/ml doxorubicin) groups. A higher tumour growth rate was, however, observed in doxorubicin-treated mice compared to the untreated controls. We therefore compared the expression levels of markers involved in cell death and survival signalling pathways, by means of western blotting and fluorescencebased immunohistochemistry. Results: Doxorubicin failed to induce cell death, by means of apoptosis or autophagy, and cell cycle arrest, indicating the occurrence of drug resistance and uncontrolled proliferation. Activation of the MAPK/ extracellularsignal- regulated kinase (ERK) pathway contributed to the resistance observed in treated mice, while no significant changes were found with the PI3K/Akt pathway and other MAPK pathways. Significant changes were also observed in cell cycle p21 and DNA replication minichromosome maintenance 2 proteins. No significant changes in EMT markers were observed after doxorubicin treatment. Conclusions: Our results suggest that doxorubicin-induced drug resistance and tumour growth can occur through the adaptive role of the MAPK/ERK pathway in an effort to protect tumour cells. Previous studies have shown that the efficacy of doxorubicin can be improved by inhibition of the ERK signalling pathway and thereby treatment failure can be overcome.
  • Thumbnail Image
    Item
    The role of bile acids in nutritional support
    (BioMed Central, 2018-09-30) Van Niekerk, Gustav; Davis, Tanja Andrea; De Villiers, Willem; Engelbrecht, Anna-Mart
    Abstract: Nutritional support continues to receive much attention as a possible intervention to prevent loss of lean tissue mass, promote recovery and re-establish proper immune function in critical care patients. Yet there remains much controversy regarding the clinical efficacy of such interventions. In addition to the direct effect of nutrition in terms of micro- and macronutrient content, nutritional formulations may exert an effect via the physiological response to feeding. Here, we highlight the key role of postprandial reabsorbed bile acids in attenuating both the inflammatory response and autophagy. These observations suggest that not all patients would benefit from aggressive nutritional support.
  • Thumbnail Image
    Item
    The role of the AHNAK protein in breast cancer : implications for tumour metastasis and chemoresistance
    (Stellenbosch : Stellenbosch University, 2016-12) Davis, Tanja Andrea; Engelbrecht, Anna-Mart; Loos, Benjamin; Stellenbosch University. Faculty of Science. Dept. of Physiological Sciences.
    ENGLISH ABSTRACT: Introduction – Cancer continues to have a significant impact on society. While there has been much success in characterising tumours and identifying targetable markers, two major problems are still faced today, namely therapeutic failure and advanced progression of the disease. The human AHNAK protein is a giant scaffold protein involved in multiple cellular processes and has now also been suggested to be associated with cancer, particularly with regards to tumour metastasis and chemoresponse. However, limited information and several contradicting findings have contributed to a poor understanding of the role of AHNAK in cancer. Thus, we aimed to characterise the AHNAK protein in cancer by determining the role of the protein in the chemotherapeutic response of breast cancer to doxorubicin (DXR) and also in cellular migration. Methods – For the in vitro model the non-metastatic DXR-sensitive epithelial-like MCF-7 and metastatic DXR-resistant mesenchymal-like MDA-MB-231 cell lines were used. We performed DXR treatments and assessed AHNAK’s protein expression and intracellular localisation. We also assessed these properties in a tumour-bearing mouse model. AHNAK knockdown and overexpression was achieved by means of transient plasmid transfections in both cell lines and following DXR treatments we assessed apoptotic marker expression, cell cycle modulation, epithelial-mesenchymal transition (EMT) marker expression and cellular migration. Results – DXR induced dose-independent and dose-dependent changes in AHNAK protein expression in MCF-7 and MDA-MB-231 cells, respectively, but it did not affect its intracellular localisation in these cells. In the tumour-bearing mouse model DXR also induced dose-dependent changes in AHNAK expression without affecting its localisation, similar to the MDA-MB-231 cells. In the MDA-MB-231 cells, DXR promoted apoptosis inhibition by decreasing cPARP and cCasp7 expression. Knockdown of AHNAK prevented this inhibition while overexpression induced a similar inhibitory effect. With cell cycle analyses we observed that DXR also resulted in S phase arrest in these cells. AHNAK knockdown completely prevented the DXR-induced cell cycle arrest while overexpression was sufficient to cause such an arrest on its own. No significant effects were observed with these experiments in the MCF-7 cells. DXR induced EMT in the MCF-7 cells but AHNAK knockdown or overexpression did not affect this. In MDA-MB-231 cells DXR treatment showed a trend of decreased EMT and while AHNAK knockdown had no effect on this, its overexpression showed clearer evidence of EMT reduction. AHNAK knockdown also had no major effects on cell migration in both cell lines, although its overexpression generally decreased cellular migration. Conclusions – We show that AHNAK plays a novel role in the DXR-response of breast cancer cells and this involved AHNAK’s expression, apoptosis inhibition and cell cycle modulation. Possible molecular mechanisms are proposed but require further investigation. Our results regarding the role of AHNAK in tumour cell migration is less clear and contradicting when compared to other studies. These results may have potential therapeutic implications with regards to the modulation of DXR response to improve treatment efficacy.
  • Thumbnail Image
    Item
    Was the evolutionary road towards adaptive immunity paved with endothelium?
    (BioMed Central, 2015) Van Niekerk, Gustav; Davis, Tanja Andrea; Engelbrecht, Anna-Mart
    Background: The characterization of a completely novel adaptive immune system (AIS) in jawless vertebrates (hagfish and lampreys) presents an excellent opportunity for exploring similarities and differences in design principles. It also highlights a somewhat neglected question: Why did vertebrates, representing only 5 % of all animals, evolve a system as complex as an AIS twice, whereas invertebrates failed to do so? A number of theories have been presented in answer to this question. However, these theories either fail to explain why invertebrates would not similarly develop an AIS and are confounded by issues of causality, or have been challenged by more recent findings. Presentation of the hypothesis: Instead of identifying a selective pressure that would drive the development of an AIS, we hypothesise that invertebrates failed to develop an AIS because of the evolutionary constraints imposed by these animals’ physiological context. In particular, we argue that a number of vascular innovations in vertebrates allowed the effective implementation of an AIS. A lower blood volume allowed for a higher antibody titer (i.e., less ‘diluted’ antibody concentration), rendering these immune effectors more cost-effective. In addition, both a high circulatory velocity and the ability of endothelium to coordinate immune cell trafficking promote ‘epitope sampling’. Collectively, these innovations allowed the effective implementation of AIS in vertebrates. Testing the hypothesis: The hypothesis posits that a number of innovations to the vascular system provided the release from constraints which allowed the implementation of an AIS. However, this hypothesis would be refuted by phylogenetic analysis demonstrating that the AIS preceded these vascular innovations. The hypothesis also suggests that vascular performance would have an impact on the efficacy of an AIS, thus predicting a correlation between the vascular parameters of a species and its relative investment in AIS. The contribution of certain vascular innovations in augmenting immune functionality of an AIS can be tested by modelling the effect of different vascular parameters on AIS efficacy. Implications of the hypothesis: The hypothesis not only explains the immunological dimorphism between vertebrates and invertebrates but also brings to attention the fact that immunity is dependent on more than just an immune system.